CRT 2017 : FDA VALVE - Transcatheter Mitral Therapy: Emerging Therapies for FMR

Conference

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview

FDA VALVE - Transcatheter Mitral Therapy: Emerging Therapies for FMR

Featuring

  • JoAnn Lindenfeld
  • Vinayak Bapat
  • Ori Ben-Yehuda
  • John Laschinger

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Moment Components

Current State of Therapy for FMR and Evidence to Support a Change – The HF Cardiologist View - JoAnn Lindenfeld
Role of Surgery in FMR - The Surgeon View - Vinayak Bapat
Role of Device Therapy in FMR - The Interventionalist View - Ori Ben-Yehuda
Study Designs for FMR - The FDA View - John Laschinger

Target Audience

Learning Objectives

Related Moments

Echocardiographic Evaluation of Aortic Stenosis – Normal Flow and Low Flow Scenarios
Journal
Article on Echocardiographic Evaluation of Aortic Stenosis – Normal Flow and Low Flow Scenarios
CRT 2015 Endovascular - Vein Management
Conference
A session on Embolic Protection and Filters from CRT 2015
The Role of MicroRNAs in Antiarrhythmic Therapy for Atrial Fibrillation
Journal
Article on The Role of MicroRNAs in Antiarrhythmic Therapy for Atrial Fibrillation
Loading Simple Education